You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

CHLORPROMAZINE HYDROCHLORIDE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Chlorpromazine Hydrochloride, and what generic alternatives are available?

Chlorpromazine Hydrochloride is a drug marketed by Actavis Mid Atlantic, Genus, Pharm Assoc, Wockhardt, Abraxis Pharm, Deva Hlding, Dr Reddys, Eugia Pharma, Gland Pharma Ltd, Hikma, Marsam Pharms Llc, Watson Labs, Wyeth Ayerst, Zydus Pharms, Alpharma Us Pharms, Abbott, Alembic, Amneal Pharms Co, Appco, Chartwell Rx, Cycle, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Kv Pharm, Lannett Co Inc, Lederle, Lupin, MSN, Purepac Pharm, Pvt Form, Sun Pharm, Teva Pharms, Upsher Smith Labs, Vangard, West Ward, and Zydus Lifesciences. and is included in seventy NDAs.

The generic ingredient in CHLORPROMAZINE HYDROCHLORIDE is chlorpromazine hydrochloride. There are twenty-four drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the chlorpromazine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Chlorpromazine Hydrochloride

A generic version of CHLORPROMAZINE HYDROCHLORIDE was approved as chlorpromazine hydrochloride by ZYDUS LIFESCIENCES on January 17^th, 2020.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for CHLORPROMAZINE HYDROCHLORIDE?
What are the global sales for CHLORPROMAZINE HYDROCHLORIDE?
What is Average Wholesale Price for CHLORPROMAZINE HYDROCHLORIDE?

Summary for CHLORPROMAZINE HYDROCHLORIDE

US Patents:	0
Applicants:	36
NDAs:	70
Finished Product Suppliers / Packagers:	28
Raw Ingredient (Bulk) Api Vendors:	129
Clinical Trials:	37
Patent Applications:	2,243
DailyMed Link:	CHLORPROMAZINE HYDROCHLORIDE at DailyMed

Drug patent expirations by year for CHLORPROMAZINE HYDROCHLORIDE

Recent Clinical Trials for CHLORPROMAZINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Cancer Prevention Research Institute of Texas	Phase 2/Phase 3
Sadat City University	Phase 1/Phase 2
Varun Monga, MD	Phase 1

See all CHLORPROMAZINE HYDROCHLORIDE clinical trials

Pharmacology for CHLORPROMAZINE HYDROCHLORIDE

Drug Class	Phenothiazine

Anatomical Therapeutic Chemical (ATC) Classes for CHLORPROMAZINE HYDROCHLORIDE

N05AA	Phenothiazines with aliphatic side-chain
N05A	ANTIPSYCHOTICS
N05	PSYCHOLEPTICS
N	Nervous system

N05AA	Phenothiazines with aliphatic side-chain
N05A	ANTIPSYCHOTICS
N05	PSYCHOLEPTICS
N	Nervous system

US Patents and Regulatory Information for CHLORPROMAZINE HYDROCHLORIDE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lannett Co Inc	CHLORPROMAZINE HYDROCHLORIDE	chlorpromazine hydrochloride	TABLET;ORAL	212996-004	Jan 22, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Pharms	CHLORPROMAZINE HYDROCHLORIDE	chlorpromazine hydrochloride	TABLET;ORAL	215659-001	Oct 25, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Chartwell Rx	CHLORPROMAZINE HYDROCHLORIDE	chlorpromazine hydrochloride	TABLET;ORAL	080439-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Amneal Pharms Co	CHLORPROMAZINE HYDROCHLORIDE	chlorpromazine hydrochloride	TABLET;ORAL	209755-004	Sep 10, 2018	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Msn	CHLORPROMAZINE HYDROCHLORIDE	chlorpromazine hydrochloride	TABLET;ORAL	214827-003	Jan 27, 2022	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	CHLORPROMAZINE HYDROCHLORIDE	chlorpromazine hydrochloride	TABLET;ORAL	085959-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Cycle	CHLORPROMAZINE HYDROCHLORIDE	chlorpromazine hydrochloride	TABLET;ORAL	085331-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.